Victory Capital Management
YTEN

Victory Capital Management’s Yield10 Bioscience, Inc. Common Stock YTEN Stock Holding History

Victory Capital Management’s Portfolio YTEN Stock Details YTEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-7
Closed – – 3422
2020
Q1 		$0 Buy
+7
New +$1.09K ﹤0.01% 3791
2019
Q4 		– Sell
-2
Closed -$1K – 3410
2019
Q3 		$1K Buy
+2
New +$1.59K ﹤0.01% 3736

Other funds holding YTEN

CC
Cannell & Co New York $3.15B AUM 30.62% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
HDIM
Hanson & Doremus Investment Management Burlington, Vermont $869M AUM 23.62% 1-Year Est. Return

Victory Capital Management's YTEN Position: Q2 2020 in Review

Victory Capital Management sold out of Yield10 Bioscience, Inc. Common Stock (YTEN) in Q2 2020, closing a stake of 7 shares.

Victory Capital Management first reported a position in YTEN in Q3 2019 and held it in 2 quarters. The position peaked at $1K in Q3 2019. 5 funds tracked by Wall St. Rank hold YTEN as of Q2 2020.

  • Victory Capital Management reported no remaining Yield10 Bioscience, Inc. Common Stock position as of Q2 2020 after selling out during the quarter.
  • Victory Capital Management sold 7 Yield10 Bioscience, Inc. Common Stock shares in Q2 2020.
  • Victory Capital Management first reported a position in Yield10 Bioscience, Inc. Common Stock in Q3 2019 and held it in 2 quarters.
  • Victory Capital Management's Yield10 Bioscience, Inc. Common Stock position peaked at $1K in Q3 2019.
  • 5 funds tracked by Wall St. Rank held Yield10 Bioscience, Inc. Common Stock as of Q2 2020.

Based on Victory Capital Management's 13F filing for Q2 2020, filed 7 Aug 2020.